Debbie Wasserman Schultz sold AngioDynamics Inc (NASDAQ: ANGO)
Debbie Wasserman Schultz sold ANGO · disclosed July 25, 2025
Debbie Wasserman Schultz, a FL House member representing District 25, sold $1,001 - $15,000 of AngioDynamics Inc (ANGO) on July 16, 2025. Filings associated with Debbie Wasserman Schultz disclosed 1 other ANGO transaction (1 purchase) in the 12 months before this trade. Shares of ANGO have risen 22.5% since the first observed purchase on April 27, 2016. The filing was publicly disclosed on July 25, 2025; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Debbie Wasserman Schultz's complete filing history, visit Debbie Wasserman Schultz's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on ANGO break down as 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell.
- ANGO carries a Risk Score of 89 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
- Debbie Wasserman Schultz sold ANGO in the amount range of $1,001 - $15,000 on July 16, 2025, filed under the STOCK Act.
- The filing lists Self as the transaction owner and was disclosed 9 days after the trade.
- The asset description in the filing reads 'AngioDynamics, Inc. - Common Stock (ANGO) [ST].'
- Filings associated with Debbie Wasserman Schultz disclosed 1 other ANGO transaction (1 purchase) in the 12 months before this trade.
- Shares of ANGO have risen 22.5% since the first observed purchase on April 27, 2016.
- ANGO carried a Q Score of 88.2 in its equity peer group as of September 8, 2026.
- ANGO carried a Squeeze Score of 22 as of September 9, 2026.
Did Debbie Wasserman Schultz buy or sell ANGO?
The Periodic Transaction Report covers a single sale involving ANGO on July 16, 2025. The filed amount range is $1,001 - $15,000. The asset description reads 'AngioDynamics, Inc. - Common Stock (ANGO) [ST]', as submitted by the filer. The report was submitted on July 25, 2025. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Debbie Wasserman Schultz (House) | Sell | ANGO | $1,001 - $15,000 | July 16, 2025 | July 25, 2025 |
What other ANGO trades has Debbie Wasserman Schultz disclosed in the past 12 months?
Filings associated with Debbie Wasserman Schultz disclosed 1 other ANGO transaction (1 purchase) in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| June 27, 2025 | Buy | Dependent child | $1,001 - $15,000 | Filing unavailable |
What does the filing show, and what does it not show?
The filing reports a sale involving ANGO by Debbie Wasserman Schultz in the amount range of $1,001 - $15,000, with Self listed as the owner. It does not establish Debbie Wasserman Schultz's total holdings in ANGO, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'AngioDynamics, Inc. - Common Stock (ANGO) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Debbie Wasserman Schultz's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Debbie Wasserman Schultz disclosed 1 other ANGO transaction (1 purchase) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded ANGO?
Quantellect's current database lists these recent ANGO disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| No recent disclosures by other members are available. | ||||
How has Debbie Wasserman Schultz's disclosed trading performed?
Debbie Wasserman Schultz holds a Quantellect Q Score of 79 (solid), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.
Q Score rank #17 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.
All Debbie Wasserman Schultz ANGO trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did Debbie Wasserman Schultz buy or sell ANGO?
According to the disclosure, Debbie Wasserman Schultz sold ANGO on July 16, 2025.
What amount was reported for the ANGO transaction?
The disclosure reports $1,001 - $15,000 for the sale. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated July 16, 2025, and it was disclosed on July 25, 2025.
Where can I see Debbie Wasserman Schultz's other congressional trades?
Quantellect lists Debbie Wasserman Schultz's complete disclosed trade history on the member profile. Debbie Wasserman Schultz's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.